Amgen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. 

CEO
Robert A. Bradway
CEORobert A. Bradway
Employees
31,500
Employees31,500
Headquarters
Thousand Oaks, California
HeadquartersThousand Oaks, California
Founded
1980
Founded1980
Employees
31,500
Employees31,500

AMGN Key Statistics

Market cap
194.94B
Market cap194.94B
Price-Earnings ratio
26.02
Price-Earnings ratio26.02
Dividend yield
2.62%
Dividend yield2.62%
Average volume
3.08M
Average volume3.08M
High today
$373.98
High today$373.98
Low today
$359.47
Low today$359.47
Open price
$373.42
Open price$373.42
Volume
361.44K
Volume361.44K
52 Week high
$391.29
52 Week high$391.29
52 Week low
$269.77
52 Week low$269.77

Stock Snapshot

As of today, Amgen(AMGN) shares are valued at $361.19. The company's market cap stands at 194.94B, with a P/E ratio of 26.02 and a dividend yield of 2.62%.

During the trading session on 2026-07-06, Amgen(AMGN) shares reached a daily high of $373.98 and a low of $359.47. At a current price of $361.19, the stock is +0.5% higher than the low and still -3.4% under the high.

Trading activity shows a volume of 361.44K, compared to an average daily volume of 3.08M.

The stock's 52-week range extends from a low of $269.77 to a high of $391.29.

The stock's 52-week range extends from a low of $269.77 to a high of $391.29.

AMGN News

Investing.com 3h
Cantor Fitzgerald reiterates Amgen stock Neutral rating at $350 - Investing.com

...

Cantor Fitzgerald reiterates Amgen stock Neutral rating at $350 - Investing.com
Simply Wall St 19h
Amgen Could Be 45% Below Fair Value As Court Blocks Enbrel Price Cap

Amgen (AMGN) is back in focus after a federal judge blocked Colorado’s proposed 70% price cap on Enbrel, which removed an immediate regulatory threat to one of...

Amgen Could Be 45% Below Fair Value As Court Blocks Enbrel Price Cap
The Motley Fool 2d
Alphabet Officially Joins the Dow. These 3 Dow Dividend Stocks Are Better Buys for July.

The Dow Jones Industrial Average looks different this month. Before trading opened on June 29, Alphabet (GOOGL 0.23%) (GOOG 0.48%) took Verizon Communications'...

Alphabet Officially Joins the Dow. These 3 Dow Dividend Stocks Are Better Buys for July.

Analyst ratings

49%

of 35 ratings
Buy
40%
Hold
48.6%
Sell
11.4%

More AMGN News

Nasdaq 3d
Roche Reports Positive Results From Head-to-Head Study on NSCLC Drug

Roche RHHBY reported positive results from the late-stage Krascendo 1 study evaluating experimental candidate, divarasib, in patients with previously treated KR...

Roche Reports Positive Results From Head-to-Head Study on NSCLC Drug
TipRanks 4d
Amgen’s Rocatinlimab Asthma Trial Reaches Phase 2 Finish Line

Amgen Inc (AMGN) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium for more c...

Simply Wall St 4d
Does Tavneos Retraction And Possible Withdrawal Reshape The Bull Case For Amgen?

The New England Journal of Medicine has retracted the pivotal Tavneos study and, following regulatory concerns over severe liver injuries, both the FDA and Euro...

Does Tavneos Retraction And Possible Withdrawal Reshape The Bull Case For Amgen?
Benzinga 5d
Micron, Palo Alto, Apple And A Health Care Stock On CNBC’s ‘Final Trades’

Supporting his view, Cantor Fitzgerald analyst C.J. Muse maintained Micron with an Overweight rating on June 29 and raised the price target from $1,500 to $2,00...

Micron, Palo Alto, Apple And A Health Care Stock On CNBC’s ‘Final Trades’
Nasdaq 6d
Alphabet Just Joined the Dow Jones Industrial Average. 3 Dow Dividend Stocks to Buy Now.

Key Points Cisco Systems is on a roll with its AI-powered platform. Coca-Cola saw volume growth in each of its marketing segments in the first quarter. Amgen...

Alphabet Just Joined the Dow Jones Industrial Average. 3 Dow Dividend Stocks to Buy Now.
TipRanks 7d
Trial used to approve Amgen’s Tavneos retracted from NEJM

A clinical trial, originally published in 2021, which was used to approve Amgen’s (AMGN) Tavneos was retracted Monday from the New England Journal of Medicine a...

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.